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a b s t r a c t 
Malaria and schistosomiasis continue to contribute a big burden to infectious disease 
prevalence in the tropical areas, mainly in sub Saharan African countries. We previously 
reported high levels of schistosome specific antibody IgG3 in children coinfected with 
malaria and schistosomiasis. The aim of the current study was to examine the current 
co-infection rates of these diseases in Nigeria. Published and unpublished studies on co- 
infection of human urogenital schistosomiasis and malaria carried out in Nigeria between 
2001 and August 2018 were retrieved through literature searches in PubMed, Google 
Scholar, AJOL, and university theses repositories. The filtered and relevant articles were re- 
viewed and combined in a meta-analysis. Studies involving children reported higher rates 
of coinfection. The fourteen research articles involving 6,559 individuals were combined 
in a meta-analysis. Our analyses revealed an estimated 15% co-infection for the country, 
though with wide variability depending on location. In addition, there are few and well- 
designed research publications in Nigeria on prevalence and mechanism of malaria and 
schistosomiasis coinfection. 
© 2019 The Author(s). Published by Elsevier B.V. on behalf of African Institute of 
Mathematical Sciences / Next Einstein Initiative. 
This is an open access article under the CC BY license. 







Malaria and schistosomiasis remain causes of high morbidity and mortality in the tropics and sub-tropics of Africa [1] .
According to the World Health Organization (WHO), both parasitic diseases are endemic to Sub-Saharan Africa with more
than 194 million malaria cases, and an estimated 91.4% requiring preventive chemotherapy. In 2016, more than 10 0,0 0 0
malaria deaths were reported in Nigeria with Plasmodium falciparum responsible for all malaria cases [2] . Infected individuals
exhibit mild symptoms ranging from fever, fatigue, chills to severe complications including cerebral malaria, austere anaemia
or renal failure [3] . ∗ Corresponding author. 
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Schistosomiasis is caused by five identified Schistosoma species and is ranked second to malaria as a neglected tropical
disease. In Nigeria, Schistosoma haematobium and Schistosoma mansoni are responsible for almost all the cases of schistoso-
miasis, causing urogenital and intestinal schistosomiasis, respectively [4] . People infected with Schistosoma spp ( S. haema-
tobium or S. mansoni ) display various symptoms and pathologies including anaemia, growth retardation (prevalent among
school aged children), dysuria, nutritional deficiencies, haematuria [5] , hepatosplenomegaly, pelvic discomfort, infertility (in
prolonged cases in females) and bladder cancer [6] . 
Several epidemiological and immunological studies have indicated high rates of co-infection with soil transmitted 
helminths and Plasmodium falciparum in conditions of poverty, where they frequently overlap [7] . Schistosomiasis and
malaria exhibit almost similar distribution patterns, making schisto-malaria coinfection a predominant occurrence in malaria
endemic countries [2] . Studies conducted in Nigeria have reported conflicting results about whether Schistosoma coinfection
with Plasmodium falciparum regulates the outcome of malaria infections, by altering the pathophysiological and immune
responses of the disease [8] . Morenikeji et al. [9] reported higher anti- Schistosoma IgG production during co-infection with
malaria among school aged children. Anumudu et al. [10] found high levels of schistosome specific antibody IgG3 in children
coinfected with malaria and schistosomiasis. 
There is little information about the prevalence of Schistosoma co-infection with Plasmodium falciparum in Nigeria. Hence,
the main objective of this systematic review and meta-analysis is to estimate the current prevalence of Schistosoma and
Plasmodium falciparum co-infection in Nigeria. 
Materials and methods 
Searches were conducted for all publications on schistosomiasis co-infection with Plasmodium falciparum in relevant aca-
demic research databases including Google scholar, PubMed, Elsevier, Biomed, PLosOne, Science Direct and African journal
online (AJOL) published between 2001 and August 2018. Relevant postgraduate theses on schistosomiasis and malaria co-
infection were also included in the study. 
The search terms used were “co-infection” OR “concomitant” OR “Mixed infection” OR “concurrent” with “schistosomia- 
sis” OR “Bilharziasis” OR “Neglected tropical disease (NTD)” OR “helminths” OR “Schistosoma ” combined with “Plasmodium 
falciparum” OR “malaria” and “Nigeria”. The search was limited to human infections. 
Inclusion criteria 
All epidemiological and immunological studies conducted in Nigeria, published in English, which reported prevalence of
S. haematobium and/or S. mansoni with Plasmodium falciparum co-infection were included in this review. All study designs
including cross-sectional, longitudinal and observational were included. In addition, studies involving school aged children,
adolescent and adults were included if they were published within the stipulated time frame. Unpublished studies, con-
ference papers and reviews on Schistosoma co-infection with Plasmodium falciparum that had data on prevalence were also
included in our study. Any soil transmitted helminth co-infection with Plasmodium falciparum studies which had prevalence
data on Schistosoma co-infection with P. falciparum were included. 
Exclusion criteria 
Studies were excluded if after full review, crucial prevalence data on Schistosoma and Plasmodium falciparum co-infection
were missing. Moreover, studies outside of the stipulated time range of this work, and those written in languages other than
English or those without prevalence data on a specific Nigerian population, were excluded. 
Outcome measures 
The primary outcome measured was the prevalence of Schistosomiasis and Plasmodium falciparum co-infections. Studies 
included in this review indicated the species of Schistosoma involved with P. falciparum co-infection. 
Data collection 
After screening individual articles for eligibility for inclusion in our study, information about the author, year of study,
study area (classified based on the geo-political zone), sample size, study design, age range, Schistosoma species investigated,
the prevalence of Schistosoma and Plasmodium falciparum were coded using Microsoft Excel, and data were analyzed using
R and MedCalc. 
Results 
The search yielded a total of 157 articles aggregated from Pubmed ( n = 4), African Journal online database ( n = 5), Google
Scholar ( n = 144) and other sources ( n = 4). Screening and Assessment of the articles revealed 32 duplicate articles. Subse-
quently, a total of 125 articles were reviewed and 103 were excluded for irrelevance. Afterwards, the remaining 22 full text
articles were examined, eight lacked some component data and 14 were finally included in the meta-analysis ( Fig. 1 ). 
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The attributes of the cross-sectional studies included in this work are shown in the table of summaries ( Table 1 ). Only
one study involved S. mansoni and P. falciparum co-infection. 
Overall prevalence 
From the literature search, the reported overall prevalence of schistosomiasis and Plasmodium falciparum co-infection in
Nigeria ranged from 3.4% to 77% ( Table 1 ). Subgroup analysis according to the geopolitical zone of the study population
especially school aged children revealed a diverse prevalence of schistosomiasis and Plasmodium falciparum co-infection.
Those reporting highest prevalence (77.0%) were carried out in southwestern Nigeria compared with lower rates from studies
performed in the South and North central zones. More data have been noted in the south west, 10 out of 17 ( Table 1 ). By
the year of article publication, the highest prevalence (77%) was recorded in 2005 and the lowest (6%) in 2012. The study
reporting the lowest co-infection prevalence (3.4%) involved adults or pregnant women. 
Meta-analysis 
A meta-analysis of combined data from 14 studies reporting on co-infection of malaria and schistosomiasis in Nigeria
was carried out. First, the overall content of the meta-analysis was examined to search for systemic bias. The possibility of
systemic publication bias did not reach statistical significance (Egger regression p = 0.354, Begg’s rank correlation p = 0.063).
There was significant heterogeneity in the reports of research studies covered ( p < 0.001) which may be observed from
the distribution patterns of individual study effect and asymmetry in the funnel plot ( Figs. 2 and 3 ). 
The confidence interval analysis showed that the robust estimates of coinfection prevalence reports ranged from 0.6% to



















































Summary of Schistosoma and Plasmodium falciparum co-infection studies in Nigeria 2001–2018. 




Study Design Sample 
Size 











1 Adedoja et al. [19] 2015a Kwara North Central Cross sectional 1017 4–15years School Children 9.52 S. haematobium 10.4% 106 
2 Adedoja et al. [20] 2015 Kwara North Central Cross sectional 159 1–15years School Children 8.35 S. haematobium 54.4% 56 
3 Adedoja et al. [23] 2017 Kwara North Central Cross sectional 309 4–15years School Children 9.7 S. haematobium 25.1% 62 
4 Anumudu et al. [10] 2012 Ibadan & 
Akure 
South West Cross sectional 163 ——— School Children ——— S. haematobium 6.0% 10 
5 Arinola, O.G [21] 2005 Ibadan South West Cross sectional 147 6–14years School Children —— S. haematobium 77.0% 14 
6 Atanda O.S [22] 2014 Ijaka Oke South West Cross sectional 202 6–14years School Children 11.5 S. haematobium 34.1% 57 
7 Dakul et al. [7] 2001 Jinduut North Central Cross sectional 110 5–15years School Children 10.3 S. haematobium 11.8% 13 
8 Egwunyenga et al. [12] 2001 Jos North Central Cross sectional 2104 ——— Pregnant Women ——— S. mansoni 3.4% 28 
9 Elenwo et al. [24] 2014 Rivers South Cross sectional 1060 0–83years All Age group ——— S. haematobium 55.1% 584 
10 Eleng I.E [13] 2015 Ijaka 
Isale 
South West Cross sectional 173 6–15years School Children 11.4 S. haematobium 57.1% ——
11 Morenikeji et al. [25] 2014 Yewa 
North 
South West Cross sectional 202 6–18years School Children 11.5 S. haematobium 28.2% –––
12 Morenikeji et al. [9] 2015 Yewa 
North 
South West Cross sectional 173 6–18years School Children 11.4 S. haematobium 57.1% –––
13 Okafor et al. [26] 2007 Rivers South Cross sectional 200 0–14years School Children ––– S. haematobium 75.0% 187 
14 Oladele et al. [8] 2014 Eggua & 
Omi-Adio 
South West Cross sectional 240 5–15years School Children ––– S. haematobium 16.0% 20 
15 Olayinka P.I [27] 2018 Yewa 
North 
South West Cross sectional 240 10–70years All Age group ––– S. haematobium 8.5% 5 
16 Ologunde et al. [28] 2015 Ise Ekiti South West Cross sectional 200 4–15years School Children ––– S. haematobium 51.0% 102 
17 Oloyede et al. [29] 2017 Ibarapa South West Cross Sectional 408 1–50years All Age group 28.35 S. haematobium 17.1% 37 
O.E. Ojo, A.S. Adebayo and H.O. Awobode et al. / Scientific African 6 (2019) e00186 5 
Fig. 2. Forest plot showing the real proportion in the prevalence of P. falciparum malaria co-infection with S. haematobium and greater effect in south-south 
region. 
Fig. 3. There was significant heterogeneity in the research studies ( p < 0.001) which may be observed from the asymmetry in the funnel plot, although 
systemic publication bias did not reach full statistical significance (Egger regression p = 0.354, Begg’s rank correlation p = 0.063). 
Table 2 
Confidence Interval analysis of estimates of co-infection. 
Study Sample size Proportion (%) 95% CI 
Adedoja et al. 2015 1017 10.423 8.612 to 12.466 
Adedoja et al.2015b 159 35.220 27.821 to 43.181 
Adedoja et al. 2017 309 20.065 15.744 to 24.970 
Anumudu et al. 2012 163 6.135 2.981 to 10.993 
Arinola, O.G 2005 147 9.524 5.305 to 15.463 
Atanda O. 2014 202 28.218 22.126 to 34.962 
Dakul et al. 2015 110 11.818 6.445 to 19.361 
Egwunyenga et al.2001 2104 1.331 0.886 to 1.918 
Elenwo et al. 2014 1060 55.094 52.042 to 58.118 
Okafor et al. 2007 200 93.500 89.141 to 96.494 
Oladele et al. 2014 240 8.333 5.164 to 12.577 
Olayinka P. 2018 240 2.083 0.680 to 4.795 
Ologunde et al. 2015 200 51.000 43.852 to 58.118 
Oloyede et al. 2017 408 9.069 6.466 to 12.283 
Total (fixed effects) 6559 14.993 14.138 to 15.879 
Total (random effects) 6559 21.400 9.025 to 37.273 
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Fig. 4. Forest plot showing the difference in the prevalence of co-infection in the range of 0.09 to 0.39 (diamond shape) but more likely close to 0.15 (if 


































location of study in the country as well as age group and social stratum targeted. However, the actual proportion of co-
infection was in the range of 0.09 to 0.39 (diamond shape) but with expected mean of 0.15 (or 15%) (if studies are assumed
to have similar effect size) ( Figs. 2 and 4 ).The greatest effect on the co-infection data was exerted by the two studies in the
south-south region which contributed high proportions ( Figs. 2 and 4 ). Higher levels of heterogeneity were contributed by
Ologunde et al. [28] and Okafor and Elenwo [26] compared to other studies, because co-infection was reported relative to
the sample sizes of their study population ( Fig 5 ). 
Discussion 
In the current study, we performed a combined analysis of more than 60 0 0 individuals from 14 retrieved research ar-
ticles on co-infection of malaria and schistosomiasis in Nigeria. Estimated co-infection rate was 15% (1SD = 9% −39%). There
was wide variability in the reports of the co-infection and sample sizes across the studies. Extreme co-infection rates may
reach as high 96.4% in small-sized, child-focused studies. The low level of co-infection research across the country re-
trieved was surprising, and almost 60% (10/17) of those retrieved were carried out in the southwest. An overview of the
studies retrieved from the literature search showed that studies involving children had higher co-infection rates. This find-
ing of a higher prevalence of P. falciparum infection among children infected with Schistosoma could result from social or
environmental factors. In some of the children-based reports, more than one-third of the analysed study population had
both schistosomiasis and malaria. There are previous reports on co-infection dynamics in children. The different intensi-
ties of Schistosoma and P. falciparum co-infection have been surmised to be based on the age of the host and intensity of
Schistosoma infection [11] . School aged children co-infected with S. mansoni may be more susceptible to P. falciparum in-
fection because anaemia associated with Schistosoma infection may cause hyperventilation of carbon dioxide and increased
lactates, making infected individuals more attractive for mosquitoes and thus increasing their risk for Plasmodium infection
[12] . 
Despite the fact that concomitant parasitic infections are a common occurrence in different regions of the world, the
small number of research articles retrieved was surprising, especially since schistosomiasis and malaria are among parasitic
infections with high prevalence in Sub-Saharan Africa [13] . The high level of co-infection of these two has been attributed
to similar factors: poor sanitation, lack of toilet facilities, unsafe drinking water, and ineffective public health enlightenment
programme. Therefore, WaSH (safe water, Sanitation and Hygiene) strategies remain valuable against these highly prevalent
tropical pathologies. 
Three cross-sectional studies included in our work investigated the modulating effect of Schistosomiasis inf ection on the
parasitaemia level of Plasmodum falciparum. Schistosoma co-infection with Plasmodium in a patient can alter the development
of acquired immunity associated with the resistance or pathology of schistosomiasis activating varied cytokine responses.
The type of immune responses depends on the Schistosoma species, host age, worm burden and Plasmodium spp. involved.
Schistosoma infection induces helper T cell (Th2) responses which alter cellular responses against malaria parasites [14] .
Adedoja et al. [15] found higher levels of IL-10 among children with only schistosomiasis and there was no significant
association between pro-inflammatory cytokines in co-infected children. Similar results were found in Kenya [16] and in
Senegal [17] . 
The concomitant infection of two parasites may modulate the effects of each other within their host. This has been
reported extensively in different studies where pre-existing infection alters the effect of other (reviewed in [4] ). Conversely,
Schistosoma haematobium exerts a persistent stimulatory effect on the host immune system, protecting children against
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uncomplicated P. falciparum malaria [18] . This modulation effect has not been widely studied in Nigeria. In some studies,
proxies for modulation were used, and often not correctly. 
Bustinduy et al. [16] studied age-stratified profiles of IL-6, IL-10 and TNF- α cytokines in Schistosoma haematobium, Plas-
modium falciparum and other chronic parasitic co-infections in Kenyan children. They correlated these cytokine levels with
schistosomiasis and interactions with concurrent co-infections. After controlling for sex, malaria, anaemia, wasting, stunting
and other cytokines, it was shown that IL-6, IL-10 and TNF- α levels were higher among children infected with S. haema-
tobium, regardless of S. haematobium co-infection status. Morenikeji et al. [9] showed that anti-Schistosoma IgG produced
during co-infection with Plasmodium spp. among infected individuals in Ijoun, Nigeria, were higher than in malaria mono
infection but not in S. haematobium mono infection; while Anumudu et al. [10] reported high levels of schistosome specific
antibody IgG3 in children co-infected with malaria and schistosomiasis in Ibadan. 
Co-infection of the two endemic parasitic diseases has socio-economic and health impact on the population according to
authors. Higher prevalence of schistosomiasis and malaria co-infection recorded in some articles included in this review was
attributed to poverty, lack of potable water, limited access to health care, lack of protective clothing, poor hygiene, poverty
and poor sanitary conditions. The geographical harmony of socio-economic and climatic conditions was also indicative of
the overlap in the distribution of Schistosoma and P. falciparum co-infection; indeed, socio-economic factors were not greatly
improved in the communities through the period of studies included in this review. In this review, we find that school










































aged children are more prone to schisto-malaria co-infection with severe anaemia, probably due to high worm load and low
immunity [1 , 8 , 9 , 22 , 25 , 28] . Females had higher co-infection rates than males and this was attributed to daily exposures to
water contact related activities including fetching water and swimming [19] . In addition, the poor socio- economic status of
the people encourages poor nutrition, and lack of adequate medical attention complicates the infections [24] . When lower
prevalence of co-infection was reported, authors indicated that this may reflect increased health awareness and improved
sanitary conditions due to gradual urbanization [29] or it may be just the reality faced in rural Nigerian communities.
Indeed, the co-infection studies reported indicate that a greater impact is due to prevailing social factors, which could be
more visible within certain societal demographics. 
Studies also reported the impact of coinfection on the overall host responses. Inyang-Etoh et al. [30] indicated that schis-
tosomiasis can have a negative effect on host response to malaria, including increased susceptibility to plasmodium infection
and increased severity of disease especially among children. These co-infected school aged children also had malnutrition,
impaired cognitive development, splenomegaly and fatigue [8] resulting in poor school performance and overall physical
work capacity. Lower haemoglobin levels were seen among pregnant women with co-infection than in those with single
infection of S. haematobium or P. falciparum [12 , 29] . Co-infection with these two parasites could aggravate renal related dis-
orders due to excess haematuria and proteinuria [9] inducing kidney complications. In treatment, modulation may even
occur such that treatment of schistosomiasis may reduce the risk of malaria infection [11 , 22] . At the moment, there is no
treatment policy for the co-infection, and often the sufferers don’t even count on the co-infection when treating the indi-
vidual infections. However, Oloyede et al. [29] suggested that artemether-lumefantrine, an antimalarial may be a possible
treatment against schistosomiasis in uncomplicated P. falciparum co-infected individuals, as it also reduces the intensity of
Schistosoma , severe anaemia and parasitemia [7 , 19 , 29] . Morenikeji et al. [9] emphasized the possibility of re-infection with
S. haematobium among the same individuals following mass chemotherapy for schistosomiasis carried out five years previ-
ously. Schistosomiasis influences the production of anti-inflammatory cytokines in children co-infected with malaria. Low 
levels of circulating T reg memory cells in co-infected children makes them susceptible to opportunistic infections [7] . To
summarize, co-infection elicits immune and other molecular responses, thus treatment or preventive strategies need to be
developed. 
Conclusion 
In essence, there has been attention on eliminating malaria and schistosomiasis, and there is research showing that co-
infection modulates immunity. However, only 22 relevant research studies reporting their co-infection in Nigeria could be
retrieved. Such a paucity of research into the dynamics of co-infection needs to be addressed, for a holistic understanding,
and rapid elimination of these two highly-prevalent diseases. 
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